Kaiser Permanente among 25 recipients of grants from National Cancer Institute’s SeroNet program.
Division of Research physician researchers and other investigators examine the pandemic’s effects from all angles.
A new study led by Permanente physician-researchers found young people felt more comfortable talking about gender identity issues when asked first by a clinician.
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
Stephen Parodi, MD, shared his insights on the field of epidemiology and what makes it personally fulfilling for him in U.S. News & World Report.
In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.
Brian Lim, MD, an interventional gastroenterologist with Southern California Permanente Medical Group, combines award-winning research with a compassionate approach to care inspired by his father.